HK1021321A1 - Novel glycolipid complexes and their uses - Google Patents

Novel glycolipid complexes and their uses

Info

Publication number
HK1021321A1
HK1021321A1 HK00100179A HK00100179A HK1021321A1 HK 1021321 A1 HK1021321 A1 HK 1021321A1 HK 00100179 A HK00100179 A HK 00100179A HK 00100179 A HK00100179 A HK 00100179A HK 1021321 A1 HK1021321 A1 HK 1021321A1
Authority
HK
Hong Kong
Prior art keywords
glycolipid
complex
diagnostic methods
novel glycolipid
glycolipid complexes
Prior art date
Application number
HK00100179A
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Jan-Eric Mansson
Original Assignee
A & Science Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Ab Publ filed Critical A & Science Ab Publ
Publication of HK1021321A1 publication Critical patent/HK1021321A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00100179A 1996-05-13 2000-01-11 Novel glycolipid complexes and their uses HK1021321A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses
PCT/SE1997/000769 WO1997042974A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses

Publications (1)

Publication Number Publication Date
HK1021321A1 true HK1021321A1 (en) 2000-06-09

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100179A HK1021321A1 (en) 1996-05-13 2000-01-11 Novel glycolipid complexes and their uses

Country Status (13)

Country Link
US (2) US6352831B1 (da)
EP (1) EP0928201B1 (da)
JP (1) JP2000513332A (da)
AT (1) ATE222775T1 (da)
AU (1) AU728141B2 (da)
CA (1) CA2253883A1 (da)
DE (1) DE69715014T2 (da)
DK (1) DK0928201T3 (da)
ES (1) ES2183177T3 (da)
HK (1) HK1021321A1 (da)
PT (1) PT928201E (da)
SE (1) SE9601817D0 (da)
WO (1) WO1997042974A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049477A1 (en) 1997-12-30 2000-11-08 A+ Science Invest AB Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
JP2009510124A (ja) * 2005-09-29 2009-03-12 トーリー パインズ インスティチュート フォー モルキュラー スタディーズ 自己免疫障害の治療のためのスルファチド
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
CA2150956A1 (en) 1992-12-10 1994-06-23 Robert G. L. Shorr Glycolipid enzyme-polymer conjugates

Also Published As

Publication number Publication date
PT928201E (pt) 2003-01-31
EP0928201A1 (en) 1999-07-14
AU2918897A (en) 1997-12-05
JP2000513332A (ja) 2000-10-10
US20020034769A1 (en) 2002-03-21
AU728141B2 (en) 2001-01-04
DE69715014D1 (de) 2002-10-02
US6352831B1 (en) 2002-03-05
EP0928201B1 (en) 2002-08-28
ATE222775T1 (de) 2002-09-15
ES2183177T3 (es) 2003-03-16
CA2253883A1 (en) 1997-11-20
DK0928201T3 (da) 2002-12-23
SE9601817D0 (sv) 1996-05-13
DE69715014T2 (de) 2004-02-26
WO1997042974A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
GB1498081A (en) Covalently bound biological substances to plastic materials and use in radioassay
TW339303B (en) Force multiplying apparatus
TR199701547T1 (xx) Polisakarit antijen protein e�leni�i i�eren a��.
AU583827B2 (en) Platinum co-ordination compounds
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
MY104946A (en) Antigen antibody conjugate.
AU4667596A (en) Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
IE873345L (en) Preparing an organ-specific substance labelled with¹technetium-99m
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
HK1021321A1 (en) Novel glycolipid complexes and their uses
ES2009312A6 (es) Dispositivo y metodo pra inmunoensayo de analitos multiples.
EP0800083A3 (en) Dye-labeled antibody conjugate and preparation method thereof
KR900005986A (ko) 항원용액중의 보조제로서 수산화아연 또는 수산화철의 용도, 및 이러한 보조제를 함유하는 항원용액
AU551802B2 (en) Anti-streptolysin o latex reagent
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
GR3009564T3 (da)
EP0389301A3 (en) Reagent complex for immunoassay
IE851279L (en) Conjugates of monovalent carboxylic ionophores
IE40645B1 (en) Visual method for the detection of syphilis and other treponemal diseases, and an antigen preparation useful therein
ES458411A1 (es) Un metodo y un aparato inmunoquimico de separacion de frac- ciones libres de las combinadas en un proceso de inmunoana- lisis.
EP0367302A3 (en) Process for semi-synthesis of human insulin, water-soluble cross-linked achromobacter protease i for use therein and a process for preparing the same
EP0407605A4 (en) Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
AU647449B2 (en) Method for the immunological determination of ligands
EP0301333A3 (en) Liposome based homogeneous immunoassay for diagnostic tests
JPS52154520A (en) Modified antibody and its preparation

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060510